Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Li Liu(Shihezi University), Tona M. Gilmer(GlaxoSmithKline (United States))
Cited by 490
Related Papers
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
|The Lancet|2014|3.2k
Health and development from preconception to 20 years of age and human capital
|The Lancet|2022|109
A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma
|Oncogene|2018|88
SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
|JNCI Journal of the National Cancer Institute|2013|79